Comparison of the effect of phenobarbital on the need for blood transfusion and neonatal phototherapy in mothers with IUT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201028049169N2

Enrollment

Registered

2021-03-17

Start date

2021-04-19

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal anemia. Fetal anemia and thrombocytopenia, unspecified trimester, fetus 1

Interventions

Intervention 1: Intervention group: In the interventional group, 30 mg phenobarbital produced with Marham Daru pharmaceutical co. (two 15 milligram tabs every 8 hours) is prescribed for ten days. Acco

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women with 17 to 35 gestational age and negative RH Fetus with positive RH and alloimmunization and anemia diagnosis Perinatal indication for intra uterine transfusion

Exclusion criteria

Exclusion criteria: Existence of any kind of anomaly in the fetus

Design outcomes

Primary

Measure	Time frame
Neonatal jaundice. Timepoint: Once. Method of measurement: Pediatric examination and Transcutaneous bilirubinometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Rahimi Sharbaf

Tehran University of Medical Sciences

rahimish@sina.tums.ac.ir+98 21 8608 9089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026